Vector List
Note: The sequencing primers listed below for each vector are
not exhaustive (only the most commonly used primers have been checked,
-21M13, M13 reverse, t7, t3, and sp6) and others not listed may also be
suitable. We also recommend that you check the exact sequence of your primer
against the vector sequence to ensure that it matches, as there are often
several slightly different versions of these common primers. When custom
primers are required, their sequences are listed.
pDeliver1.1
NAME: pDeliver1.1 (kanamycin resistant; 25 ug/ml)
SOURCE: Genecopeia
V_TYPE: Gateway entry vector
POLYLINKER SEQUENCE: not available
FULL SEQUENCE: not available
VECTOR MAP: not available
SEQUENCING PRIMERS
||
pENTR/D-TOPO
NAME: pENTR/D-TOPO (kanamycin resistant; 25 ug/ml)
SOURCE: Invitrogen Life Technologies
V_TYPE: Gateway entry vector
POLYLINKER SEQUENCE:
TAACGCTAGCATGGATGTTTTCCCAGTCACGACGTTGTAAAACGACGGCC
AGTCTTAAGCTCGGGCCCCAAATAATGATTTTATTTTGACTGATAGTGAC
CTGTTCGTTGCAACAAATTGATGAGCAATGCTTTTTTATAATGCCAACTT
TGTACAAAAAAGCAGGCTCCGCGGCCGCCCCCTTCACC-ORF-AAGGGTG
GGCGCGCCGACCCAGCTTTCTTGTACAAAGTTGGCATTATAAGAAAGCAT
TGCTTATCAATTTGTTGCAACGAACAGGTCACTATCAGTCAAAATAAAAT
CATTATTTGCCATCCAGCTGATATCCCCTATAGTGAGTCGTATTACATGG
TCATAGCTGTTTCCTGGCAGCTCTG
FULL SEQUENCE: Available here
VECTOR MAP: Available here
SEQUENCING PRIMERS: M13(-21), t7, M13 reverse
||
pENTR201
NAME: pENTR201 (kanamycin resistant; 10ug/ml)
SOURCE: Invitrogen Life Technologies
V_TYPE: Gateway entry vector
POLYLINKER SEQUENCE:
ACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACC
GCTAGCCAGGAAGAGTTTGTAGAAACGCAAAAAGGCCATCCGTCAGGATG
GCCTTCTGCTTAGTTTGATGCCTGGCAGTTTATGGCGGGCGTCCTGCCCG
CCACCCTCCGGGCCGTTGCTTCACAACGTTCAAATCCGCTCCCGGCGGAT
TTGTCCTACTCAGGAGAGCGTTCACCGACAAACAACAGATAAAACGAAAG
GCCCAGTCTTCCGACTGAGCCTTTCGTTTTATTTGATGCCTGGCAGTTCC
CTACTCTCGCGTTAACGCTAGCATGGATCTCGGGCCCCAAATAATGATTT
TATTTTGACTGATAGTGACCTGTTCGTTGCAACAAATTGATGAGCAATGC
TTTTTTATAATGCCAACTTTGTACAAAAAAGCTGGCACCATG-linker-
ORF-linker-GGCGACCCAGCTTTCTTGTACAAAGTTGGCATTATAAGA
AAGCATTGCTTATCAATTTGTTGCAACGAACAGGTCACTATCAGTCAAAA
TAAAATCATTATTTGCCATCCAGCTGCAGCTCTGGCCCGTGTCTCAAAAT
CTCTGATGTTACATTGCACAAGATAAAAATATATCATCATGAACAATAAA
ACTGTCTGCTTACATAAACAGTAATACAAGGGGTGTTATGAGCCATATTC
AACGGGAAACGTCGAGGCCGCGATTAAATTCCAACATGGATGCTGATTTA
TATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAAT
CTATCGCTTGTATGGGAAGCCCGATGCGC
FULL SEQUENCE: Available here
VECTOR MAP: Available here
SEQUENCING PRIMERS: pDONR201-reverse [GTAACATCAGAGATTTTGAGACAC], pDONR201-forward [TCGCGTTAACGCTAGCATGGATCTC]
||
pENTR221
NAME: pENTR221 (kanamycin resistant; 10ug/ml)
SOURCE: Invitrogen Life Technologies
V_TYPE: Gateway entry vector
POLYLINKER SEQUENCE:
CGACAAACAACAGATAAAACGAAAGGCCCAGTCTTCCGACTGAGCCTTTC
GTTTTATTTGATGCCTGGCAGTTCCCTACTCTCGCGTTAACGCTAGCATG
GATGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTCTTAAGCTCG
GGCCCCAAATAATGATTTTATTTTGACTGATAGTGACCTGTTCGTTGCAA
CAAATTGATGAGCAATGCTTTTTTATAATGCCAACTTTGTACAAAAAAGC
AGGCT-linker-ORF-linker-ACCCAGCTTTCTTGTACAAAGTTGGC
ATTATAAGAAAGCATTGCTTATCAATTTGTTGCAACGAACAGGTCACTAT
CAGTCAAAATAAAATCATTATTTGCCATCCAGCTGATATCCCCTATAGTG
AGTCGTATTACATGGTCATAGCTGTTTCCTGGCAGCTCTGGCCCGTGTCT
CAAAATCTCTGATGTTACATTGCACAAGATAAAAATATATCATCATGAAC
AATAAAACTGTCTGCTTACATAAACAGTAATACAAGGGGTGTTATGAGCC
ATATTCAACGGGAAACGTCGAGGCCGCGATTAAATTCCA
FULL SEQUENCE: Available here
VECTOR MAP: Available here
SEQUENCING PRIMERS: M13(-21), M13 reverse
||
pENTR223
NAME: pENTR223 (spectinomycin resistant; 100 ug/ml)
SOURCE: Dana Farber Cancer Institute/Vidal Lab
V_TYPE: Gateway entry vector
POLYLINKER SEQUENCE:
CAACAGATAAAACGAAAGGCCCAGTCTTCCGACTGAGCCTTTCGTTTTAT
TTGATGCCTGGCAGTTCCCTACTCTCGCGTTAACGCTAGCATGGATGTTT
TCCCAGTCACGACGTTGTAAAACGACGGCCAGTCTTAAGCTCGGGCCCCA
AATAATGATTTTATTTTGACTGATAGTGACCTGTTCGTTGCAACAAATTG
ATGAGCAATGCTTTTTTATAATGCCAACTTTGTACAAAAAAGTTG-link
er-ORF-linker-CCAACTTTCTTGTACAAAGTTGGCATTATAAGAAAG
CATTGCTTATCAATTTGTTGCAACGAACAGGTCACTATCAGTCAAAATAA
AATCATTATTTGCCATCCAGCTGATATCCCCTATAGTGAGTCGTATTACA
TGGTCATAGCTGTTTCCTGGCAGCTCTGGCCCGTGTCTCAAAATCTCTGA
TGTTACATTGCACAAGATAAAAATATATCATCATGCCTCCTCTAGACCAG
CCAGGACAGAAATGCCTCGACTTCGCTGC
FULL SEQUENCE: Available here
VECTOR MAP: Available here
SEQUENCING PRIMERS: M13(-21), t7
||
pENTR223.1
NAME: pENTR223.1 (spectinomycin resistant; 100 ug/ml)
SOURCE: Invitrogen Life Technologies
V_TYPE: Gateway entry vector
POLYLINKER SEQUENCE:
GCTAGCATGGATGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTC
TTAAGCTCGGGCCCCAAATAATGATTTTATTTTGACTGATAGTGACCTGT
TCGTTGCAACAAATTGATGAGCAATGCTTTTTTATAATGCCAACTTTGTA
CAAAAAAGCAGAAG-linker-ORF-linker-GCCCAGCTTTCTTGTAC
AAAGTTGGCATTATAAAAAATAATTGCTCATCAATTTGTTGCAACGAACA
GGTCACTATCAGTCAAAATAAAATCATTATTTGCCATCCAGCTGATATCC
CCTATAGTGAGTCGTATTACATGGTCAT
FULL SEQUENCE: Available here
VECTOR MAP: Available here
SEQUENCING PRIMERS: M13(-21), t7
||